this piece corresponds to the legacy myPDB login in the form of a bootstrap modal, will likely retire-->

292

N-(3-CYCLOPROPYL-1H-PYRAZOL-5-YL)-2-(2-NAPHTHYL)ACETAMIDE

292 as free ligands, exist in 1 entry. Example includes: 1VYW

Find related ligands: Stereoisomers Similar ligands Chemical Structure Search

View summary at Ligand Expo



Chemical Component Summary

NameN-(3-CYCLOPROPYL-1H-PYRAZOL-5-YL)-2-(2-NAPHTHYL)ACETAMIDE
IdentifiersN-(5-cyclopropyl-2H-pyrazol-3-yl)-2-naphthalen-2-yl-ethanamide
FormulaC18 H17 N3 O
Molecular Weight291.35 g/mol
TypeNON-POLYMER
Isomeric SMILESO=C(Cc1ccc2ccccc2c1)Nc1cc(n[nH]1)C1CC1
InChIInChI=1S/C18H17N3O/c22-18(19-17-11-16(20-21-17)14-7-8-14)10-12-5-6-13-3-1-2-4-15(13)9-12/h1-6,9,11,14H,7-8,10H2,(H2,19,20,21,22)
InChIKeyRIGZCVNCFXYBEG-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count39
Chiral Atom Count0
Chiral Atomsn/a
Bond Count42
Aromatic Bond Count16
Leaving Atomsn/a

Drug Info: DrugBank

DrugBank IDDB06944 Different stereochemistry
NameN-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide
Groupsexperimental
DescriptionN-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide is a solid. This compound belongs to the naphthalenes. These are compounds containing a naphthalene moiety, which consists of two fused benzene rings. The proteins that N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide targets include cyclin-A2 and cyclin-dependent kinase 2.
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682